DCDong Chen

Dong Chen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dong Chen has a total of 79 co-authors. Here are the top co-authors by number of shared publications:

  • Jianfeng Shang

    Capital Med Univ, Beijing Anzhen Hosp, Dept Pathol, 2 Anzhen Rd, Beijing 100029, Peoples R China

    6 shared publications
  • Wei Fang

    Department of Pathology, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China

    4 shared publications
  • Jiaqi Wang

    Capital Medical University

    3 shared publications
  • Fang Dong

    Capital Med Univ, Beijing Anzhen Hosp, Dept Pathol, 2 Anzhen Rd, Beijing 100029, Peoples R China

    2 shared publications
  • Fei Teng

    Department of Pathology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China

    2 shared publications
  • Guoliang Lian

    Department of Pathology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China

    2 shared publications

Latest Publications

  • The Largest Cohort Study of Intravenous Leiomyomatosis Reveals HMGA2 and Collagen Gene Alterations as Cooperative Drivers

    by Wei Zheng, Xia Liu, Yiwen Sun, Zijun Wang, Dong Chen, Yan Liu, Juan Du, Xiaoya Zhao, Jianfeng Shang, Yang Zhan, et al.

    Intravenous leiomyomatosis (IVL) is a rare, hormonally responsive smooth muscle neoplasm defined by nondestructive intravascular growth. Despite its distinct clinical behavior, the comprehensive molecular landscape of IVL has not been systematically characterized. We collected the clinicopathologic characteristics of 89 IVLs, 106 conventional uterine leiomyomas (cULMs), and 83 cellular leiomyomas (CLs). Using immunohistochemistry (IHC), we evaluated high mobility group AT-hook 2 (HMGA2) expression in 88 IVLs, 106 cULMs, and 83 CLs. We also assessed fumarate hydratase (FH) and 2-succinocysteine status by IHC in 82 IVLs. Fluorescence in situ hybridization was performed using the HMGA2 break-apart probe in 84 IVLs and the HMGA2/RAD51B fusion probe in 83 IVLs. We detected MED12 exon 2 hotspot mutations by Sanger sequencing in 79 IVLs. Whole-exome sequencing (WES) was performed in 10 IVLs. We found that IVL predominantly affected reproductive-aged women, most with a history of uterine trauma. HMGA2 expression was upregulated in 87.5% (77/88) of IVLs, with strong immunoreactivity in 40.9% (36/88) of IVLs. Half of IVLs harbored HMGA2 rearrangements, predominantly the HMGA2/RAD51B fusion. WES revealed frequent mutations in collagen (COL) gene family members (70.0%, 7/10), all co-occurring with HMGA2 upregulation. Conversely, MED12 exon 2 mutations (2.5%, 2/79) and FH deficiency (2.4%, 2/82) were rare events in this cohort. We propose that IVL pathogenesis likely involves synergistic interplay between dysregulated HMGA2 and COL gene family alterations within a permissive microenvironment influenced by hormones and uterine trauma. FH deficiency and MED12 exon 2 hotspot mutations appear infrequent in IVL and may not represent primary drivers of disease initiation.

  • Open Access

    A Diagnostic Dilemma of Arrhythmogenic Cardiomyopathy Masquerading as Recurrent Myocarditis in a Pediatric Patient with a DES Gene Variant: A Case Report

    by Qi Meng, Wei Li, Wenhong Ding, Hui Wang, Dong Chen, Ling Han, Yifei Li, Chencheng Dai

    Background: Arrhythmogenic cardiomyopathy (ACM) is an inherited disorder characterized by fibrofatty replacement of cardiomyocytes. The inflammatory episodes of ACM, known as the “hot phase”, can mimic acute myocarditis. It was seldom observed in a DES-associated ACM as a “hot-phase” presentation. Case Presentation: The proband, a 13-year-old female, initially presented with a series of clinical manifestations of fulminant myocarditis. Although recommendation-guided anti-immunotherapy had been provided, this patient still developed into an aggressive cardiomyopathy with biventricular dilation and severe systolic heart failure. Additionally, cardiac magnetic resonance demonstrated circumferential late gadolinium enhancement in left ventricular myocardium with diffuse fibrosis. Whole-exon sequencing identified a de novo missense variant, as c.335T>A (p.L112Q) of the DES gene, resulting in protein dysfunction. And a diagnosis of ACM due to a DES variant had been identified. Finally, this patient received heart transplantation, and biventricular fibrofatty infiltration was confirmed by pathological analysis. Conclusions: This case presented a de novo genetic variant that can induce severe and aggressive heart failure. This finding emphasizes the importance of comprehensive genetic analysis in patients suspected of having fulminant myocarditis, which would greatly benefit the precise clinical management and outcomes.

  • Open Access

    Intrapericardial cavernous hemangioma: a rare cause of persistent dyspnea and a diagnostic challenge

    by Zhiyuan Jin, Jiancheng Han, Yaxi Wang, Dong Chen, Xiaoshan Zhang

  • Open Access

    Protonation-Guided Design and Evaluation of Selective PET Tracers for Light Chain Cardiac Amyloidosis

    by Mengchao Cui, JiangXue Tang, Miao Wang, Yuying Li, Haonan Yu, Xiaojun Zhang, Meijie Pan, Qilei Zhang, Jiaqi Wang, Jiapei Dai, et al.

    Early detection of cardiac amyloidosis (CA) is challenging, despite advances in repurposed β -amyloid PET tracers and amyloid-targeted [ 124 I]Evuzamitide. The heterogeneity of CA subtypes requires invasive tests, like tissue biopsy, before targeted therapy can begin. Amyloidogenic light chains (AL) expose negatively charged pockets enriched in acidic residues and N-glycosylated modifications, guiding the design of selective molecular probes. We showed that protonation-driven recognition accomplishes unprecedented selectivity for AL deposits. Using this principle, we developed a fluorinated derivative, [ 18 F] FT-8 , based on a 4-pyridylpiperazine scaffold, which displayed high binding affinity ( K i = 11.52 nM) and selectivity towards AL, as well as favorable pharmacokinetics. In first-in-human PET studies, [ 18 F] FT-8 provided high-contrast visualization of AL deposits in the myocardium and extracardiac organs with significant specificity. These findings position [ 18 F] FT-8 as a promising PET tracer for advancing the non-invasive differential diagnosis of AL-CA and highlighting the role of protonation in developing new-generation molecular probes across diverse disease contexts.

  • Preclinical and preliminary clinical evaluation of [18F]Florbetazine for non-invasive PET detection of cardiac amyloidosis

    by Yuying Li, Meijie Pan, Haonan Yu, Qilei Zhang, Yan Chang, Hailong Zhao, Jiaqi Wang, Xiaoming Wang, Jiapei Dai, Lu Yu, et al.

    Purpose Early detection of cardiac amyloidosis (CA) remains challenging, and a PET tracer capable of directly visualizing amyloid deposits could improve diagnosis. Given the shared β-sheet structure of amyloid deposits in CA and Alzheimer’s disease (AD), this study aimed to evaluate the suitability of the AD amyloid tracer [18F]Florbetazine for non-invasive detection of CA via preclinical assessments and preliminary clinical evaluation. Methods Specific binding and affinity of [18F]Florbetazine to amyloid light-chain (AL) and transthyretin (ATTR) deposits were assessed via in vitro autoradiography on human myocardial sections. Pharmacokinetics and biodistribution were characterized by dynamic micro-PET/CT imaging in healthy Sprague Dawley (SD) rats. Whole-body PET/CT imaging was performed in two healthy volunteers to estimate normal-organ background, and in a single patient with biopsy-proven AL amyloidosis to preliminarily explore diagnostic feasibility. Results Autoradiography confirmed specific binding of [18F]Florbetazine to both AL and ATTR deposits with high binding affinities (Kd = 20.85 nM and 54.10 nM, respectively). In rats, [18F]Florbetazine exhibited rapid myocardial and renal uptake followed by efficient clearance from normal tissues. In healthy volunteers, background myocardium and renal activity was minimal by 40 min post-injection. In the AL amyloidosis patient, delayed-phase PET/CT imaging (60–70 min) revealed intense myocardium and renal uptake, correlating with renal biopsy findings. Conclusions These integrated preclinical and preliminary clinical evaluation demonstrates that [18F]Florbetazine binds cardiac amyloid with high affinity and displays favorable pharmacokinetics, warranting further investigation in larger, systematically designed clinical studies. Trial registration Clinical trial registry NCT06593626 (registered 24 May 2024) and NCT06725706 (registered 5 Dec 2024).


  • Open Access

    Idiopathic cardiac ossification with Chiari mesh in the right atrium: a case report and literature review

    by Menghan Zheng, Dong Chen, Jiaqi Wang, Jianfeng Shang, Fang Dong

    Background: Idiopathic cardiac osseous metaplasia in the right atrium of a 9-year-old boy, accompanied by right atrial Chiari network and right pulmonary artery embolism. This case is rare and can easily be misdiagnosed. Case Description: We encountered a case of a 9-year-old boy with a 3.5 cm diameter neoplasm in the right atrium. Preoperative imaging diagnosis could not determine the nature of the tumor, and the initial clinical suspicion of cardiac myxoma. After admission, a cardiotomy to remove foreign bodies and a pulmonary artery thrombectomy were performed. Conclusions: Idiopathic cardiac osseous metaplasia is relatively rare, and it is even rarer to be accompanied by a Chiari network in the right atrium. Due to the location and characteristics of the lesion in this case, it is easy to be misdiagnosed as atrial myxoma in clinical practice. Whether it is idiopathic osseous metaplasia or myxoma, it needs to be performed surgical treatment and pathological examination can easily rule out the diagnosis of myxoma. However, as idiopathic cardiac metaplasia is difficult to encounter in clinical work and there are few reports in the literature, clinicians and pathologists need to consult more relevant literature. Learn to understand and master the disease through multi-party consultation.

  • A UFO-like cavernous haemangiomas in the atrial septum visualized by three-dimensional transoesophageal echocardiography

    by Xu Yang, Jiancheng Han, Dong Chen, Yihua He

    A 55-year-old woman presented with paroxysmal chest tightness for over a month. She has a history of hypertension and takes her regularly prescribed medication, irregularly. She had surgery for a herniated disc 9 years ago. Physical examination and laboratory tests were normal. Transthoracic echocardiography showed an equal-echo mass in the middle of the atrial septum, with a wide base, extending to the right and left atrium (Panel A). Two-dimensional transoesophageal echocardiography showed a 3.5 × 4.1 cm mass in the middle and lower atrial septum, with homogeneous echo (Panel B). Three-dimensional transoesophageal echocardiography revealed a UFO-like mass in the middle of the atrial septum, with smooth and regular surfaces and clear boundaries on the left atrial view. The mass was located immediately adjacent to the aortic non-coronary sinus and the base of the anterior leaflet of the mitral valve (Panels C and D). During surgery, a dark red circular mass in the middle of the atrial septum was visualized (Panel E). The mass in the atrial septum was resected under total cardiopulmonary bypass. The post-operative course was uneventful, and the patient was discharged in a good condition 1 week after surgery. Post-operative histopathological examination revealed endothelial cells, communicating dilated vascular channels, and clusters of red blood cells inside the vascular lumen; thus, it was diagnosed as a cavernous haemangioma (Panel F).

  • Open Access

    Cardiac fibroma: A clinicopathologic study of a series of 12 cases

    by Fei Teng, Shaomin Yang, Dong Chen, Wei Fang, Jianfeng Shang, Songbo Dong, Yayan Cui, Wen Fu, Menghan Zheng, Yanwei Li, et al.